JENNIFER SWOFFORD: Open Payments
NPI 1700228350 · TROY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 85 payments from 16 companies in 2025. Trend: 2023 $232 · 2024 $1,240 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $291 |
| Amgen Inc. | 15 | $209 |
| ABBVIE INC. | 13 | $184 |
| UCB, Inc. | 4 | $172 |
| Lilly USA, LLC | 5 | $100 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $74 |
| Organon LLC | 10 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
Products named: TREMFYA, OTEZLA, SKYRIZI, Bimzelx, TALTZ, Sotyktu, ILUMYA, COSENTYX.
Industry payments across MO — which companies pay providers there.
